WAM
IMVTW

Wolverine Asset Management’s Immunovant, Inc. Warrants expiring 12/18/2024 IMVTW Stock Holding History

Wolverine Asset Management’s Portfolio IMVTW Stock Details IMVTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-275,622
Closed -$661K – 1902
2020
Q1 		$661K Buy
275,622
+174,672
+173% +$335K 0.01% 609
2019
Q4 		$201K Buy
+100,950
New +$204K ﹤0.01% 968

Wolverine Asset Management's IMVTW Position: Q2 2020 in Review

Wolverine Asset Management sold out of Immunovant, Inc. Warrants expiring 12/18/2024 (IMVTW) in Q2 2020, closing a stake of 275,622 shares — an estimated $661K sold.

Wolverine Asset Management first reported a position in IMVTW in Q4 2019 and held it in 2 quarters. The position peaked at $661K in Q1 2020. 0 funds tracked by Wall St. Rank hold IMVTW as of Q2 2020.

  • Wolverine Asset Management reported no remaining Immunovant, Inc. Warrants expiring 12/18/2024 position as of Q2 2020 after selling out during the quarter.
  • Wolverine Asset Management sold 275,622 Immunovant, Inc. Warrants expiring 12/18/2024 shares in Q2 2020, an estimated $661K.
  • Wolverine Asset Management first reported a position in Immunovant, Inc. Warrants expiring 12/18/2024 in Q4 2019 and held it in 2 quarters.
  • Wolverine Asset Management's Immunovant, Inc. Warrants expiring 12/18/2024 position peaked at $661K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Immunovant, Inc. Warrants expiring 12/18/2024 as of Q2 2020.

Based on Wolverine Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.